NEW YORK (GenomeWeb News) — OpGen has received $23.6 million in Series A private-equity financing that it plans to use to “develop commercial instrumentation systems for the clinical microbiology marketplace.”   
 
OpGen, a Madison, Wisc.-based company specializing in analyzing microbial DNA, also said it is looking for a new chief executive.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.